Excertos do catálogo
ePTFE vascular prosthesis with B ioactive luminal coating with double mechanism of action 1 ) Antithrombogenic effect for advanced hemocompatibility Injured vessel Initiation phase Fibrinogen Cross-linked Fibrin Clot Thrombin IIa Prothrombin II Catalysis Fibrin Xa Transformation Propagation phase A Clot formation PM FLOW Plus Heparin Inhibition of Thrombin Propagation phase Thrombin IIa AT III 1 B Fibrinogen Thrombin IIa 2 AT III Xa 2 3 Cross-linked Fibrin Clot Fibrin A 3 Xa Thrombin IIa Prothrombin II Xa Inhibition of Factor Xa 1 NO clot formation B Heparin binds to the antithrombin III (AT III) thanks to its bioactive site causing its conformational change and its activation. The activated AT III then inactivates proteases involved in blood clotting, most notably thrombin and Faxtor Xa. A : The formation of a complex between AT III, thrombin, and heparin results in the inactivation of thrombin. B : The conformational change in AT III on heparin-binding lead to its inhibition effect on factor Xa. Prevention of thrombosis and blood clot formation R 2 ) educed neointimal hyperplasia Heparin molecule is known to reduce neotimal hyperplasia phenomenon (1). Thus PM FLOW Plus Heparin bioactive coating helps to prevent progressive perianastomotic stenosis development which could lead to late thrombosis. (1) ai WW, Heparin coating of small-caliber decellularized xenografts reduces macrophage infiltration and intimal hyperplasia, Artif Organs. C 2009 Jun;33(6):448-55.
Abrir o catálogo na página 1Peripheral Bypass Heparin coating Acute Thromboresistance In-vivo comparative study on pig (4) (highly thrombogenic animal model). Explanted vascular grafts after challenging 3 hours implantation at the level of carotid arteries : Control ePTFE PM FLOW Plus Heparin (left carotid artery) (right carotid artery) Anastomosis area : No thrombus formation observed on the PM FLOW Plus Heparin contrary to control ePTFE Medial area : No thrombus formation observed on the PM Flow Plus Heparin contrary to control ePTFE L ong-lasting antithrombogenic activity Heparin molecules are strongly attached to...
Abrir o catálogo na página 2Peripheral Bypass ePTFE vascular prosthesis with Heparin coating Thin Wall References Wall thickness Usable length (cm) Diameter (mm) PFHT0620 TW 20 6 PFHT0720 TW 20 7 PFHT0820 TW 20 8 PFHT0640 TW 40 6 PFHT0740 TW 40 7 PFHT0840 TW 40 8 PFHT0680 TW 80 6 PFHT0780 TW 80 7 PFHT0880 TW 80 8 Wall thickness Usable length (cm) Diameter (mm) PFHTR0640 TW 40 6 PFHTR0740 TW 40 7 PFHTR0840 TW 40 8 PFHTR0680 TW 80 6 PFHTR0780 TW 80 7 PFHTR0880 TW 80 8 Thin Wall with helical reinforcement - REF DC00018/003 References This device is CE marked. Cardiovascular Division - Route du Manoir - 60173 Ivry le...
Abrir o catálogo na página 3Peripheral Bypass ePTFE vascular prosthesis with Heparin coating coating with double • Reduced neointimal antithrombogenic activity O Full range of sizes and diameters with and without helical reinforcement
Abrir o catálogo na página 4Todos os catálogos e folhetos técnicos Perouse Medical
-
PMSX
2 Páginas
-
Embolectomy catheters
2 Páginas
-
PolymailleFlow
4 Páginas
-
Polythese IC/ICT
4 Páginas
-
POLYSITE® Standard - 4000 series
1 Páginas
-
POLYSITE® Mini Adult - 3000 series
1 Páginas
-
POLYSITE® Micro - 2000 series
1 Páginas
-
POLYSITE® High Flow
1 Páginas
-
Corowl
2 Páginas
-
Alligatork
2 Páginas
-
Algaflex
2 Páginas
-
Seal One
2 Páginas
-
POLYTHESE IC / ICT
4 Páginas
-
Octoflux
2 Páginas
-
Pelicangio
2 Páginas
-
Octoflux - Angio sets
2 Páginas
-
Nautiflux
3 Páginas
-
Miniflux
4 Páginas
-
Screwing
2 Páginas
-
Myshell lite
2 Páginas
-
Dolphin
2 Páginas
-
Flamingo
2 Páginas
-
Vein stripper
2 Páginas
-
UNISTRIP® II
2 Páginas
-
POLYSTRIPP®
2 Páginas
-
PolyArt®
2 Páginas
-
POLYSHUNT®
2 Páginas
-
POLYPATCH®
2 Páginas
-
PM® Flow
4 Páginas
-
Commercial brichure - Polyarch
2 Páginas
-
Commercial brochure - PolymailleC
4 Páginas